Morgan Stanley (MS) 13D/13G Filings for NextCure, Inc. (NXTC)

Morgan Stanley 13D and 13G filings for NextCure, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-05-10
4:04 pm
Sale		 2021-04-30 13G NextCure, Inc.
NXTC		 MORGAN STANLEY
MS		 399,919
1.400%		 -1,781,699decrease
(-81.67%)		 Filing
2021-02-11
2:11 pm
Purchase		 2020-12-31 13G NextCure, Inc.
NXTC		 MORGAN STANLEY
MS		 2,181,618
7.900%		 302,638increase
(+16.11%)		 Filing
2020-10-26
4:02 pm
Purchase		 2020-10-15 13G NextCure, Inc.
NXTC		 MORGAN STANLEY
MS		 1,878,980
6.800%		 1,878,980increase
(New Position)		 Filing